NJ Appeals Court Nixes $2.6M Ruling Against Roche

Law360, New York (March 12, 2009, 12:00 AM EDT) -- In a boost for Hoffmann-La Roche Inc., a New Jersey appellate court has vacated a judgment that awarded $2.6 million to a man who claimed he had to have surgery to remove his colon after taking the acne treatment Accutane.

The New Jersey Superior Court Appellate Division on Thursday held that a trial court’s restrictions on Roche to present information to the jury on the number of Accutane users as part of its defense constituted “reversible and harmful error” and required the judgment to be scrapped...
To view the full article, register now.